サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：バイオ触媒（生体触媒）の世界市場 - 2023-2030年
市場調査レポート
商品コード
1290398

バイオ触媒（生体触媒）の世界市場 - 2023-2030年

Global Biocatalysis Market - 2023-2030

出版日
ページ情報
英文 172 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
バイオ触媒（生体触媒）の世界市場 - 2023-2030年
出版日: 2023年06月12日
発行: DataM Intelligence
ページ情報: 英文 172 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

市場概要

バイオ触媒（生体触媒）の世界市場は、2022年に6億800万米ドルに達し、2030年までに9億800万米ドルに達すると予測され、有利な成長を遂げると予想されます。市場は、予測期間中（2023-2030年）のCAGRで5.2%の成長が予測されています。

バイオ触媒は、その環境に優しい性質から支持を集めています。過酷な化学物質やエネルギー集約型のプロセスを削減し、二酸化炭素排出量や廃棄物の発生を抑えます。バイオ触媒は再生可能な資源に由来し、穏やかな条件下で作動するため、持続可能な製造方法に対する需要の高まりと合致しています。

市場力学

環境負荷の少ない材料への需要

持続可能な材料への需要は、環境問題だけでなく、消費者の嗜好にも左右されます。消費者は製品の環境影響に対する認識を深めており、持続可能で環境に優しい製品に対してより多くの費用を支払うことを望んでいます。バイオ触媒の利用により、メーカーは環境への影響を抑えながら、消費者の需要に応えることができるようになります。

バイオ触媒プロセスの開発には、研究開発への多大な投資が必要です。しかし、持続可能な材料への需要が高まるにつれ、バイオ触媒のコストは低下し、メーカーにとってより現実的な選択肢となることが期待されます。

バイオ触媒に関する欠点が市場を阻害する

バイオ触媒の欠点には、バイオ触媒の設計ができないこと、これらの触媒の安定性の限界、十分に特性化されたすぐに使える触媒の希少性などがあります。また、バイオ触媒のプロセスに必要な水の量が十分でないことも、よく取り上げられる欠点です。

COVID-19の影響分析

食品、飲料、化粧品業界からの需要の高まりは、世界の生触媒市場のCOVID-19にプラスの影響を与えます。ほとんどの国で施錠や自宅待機の指示が出されているため、飲食品事業はCOVID-19のパンデミックの影響を受けています。

ロシア・ウクライナ戦争影響分析

地政学的状況は、バイオ触媒分野における投資決定や研究の優先順位に影響を与える可能性があります。企業や研究機関は戦略を見直し、紛争の影響を受ける地域からリソースを振り向ける可能性があり、その地域のイノベーションと市場成長に影響を与える可能性があります。

人工知能の影響分析

機械学習や予測モデリングなどのAI技術は、実験データを分析し、最適な反応条件を特定することで、バイオ触媒プロセスを最適化することができます。AIアルゴリズムは、パターンを認識し、ボトルネックを特定し、プロセスの修正を提案し、効率、生産性、費用対効果を向上させることができます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 環境負荷の少ない材料への需要
    • 抑制要因
      • バイオ触媒に関する欠点が市場の妨げ
    • 機会
      • 生分解の高度な技術が有利な機会を生む
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 COVID-19の分析

第7章 タイプ別

  • オキシドレダクターゼ
  • ヒドロラーゼ
  • トランスフェラーゼ
  • その他

第8章 由来別

  • 植物
  • 動物
  • 微生物
  • その他

第9章 用途別

  • 食品・飲料
  • 洗浄剤
  • フレグランス・フレーバー
  • 農業・飼料
  • バイオ医薬品
  • 紙・パルプ
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • ロシア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第11章 競合情勢

  • 競合シナリオ
  • 市況ポジショニング/シェア分析
  • M&A（合併・買収）分析

第12章 企業プロファイル

  • Biocatalysts Limited
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展状況
  • Novozymes A/S
  • Codexis, Inc.
  • Koninklijke DSM N.V.
  • Chr. Hansen Holding A/S
  • Amano Enzyme, Inc.,
  • BASF SE
  • Fermenta Biotech Ltd
  • Piramal Enterprises Ltd.
  • EnginZyme AB.

第13章 付録

目次
Product Code: CH4954

Market Overview

The Global Biocatalysis Market reached US$ 608 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 908 million by 2030. The market is growing at a CAGR of 5.2% during the forecast period 2023-2030.

Biocatalysis is gaining traction due to its eco-friendly nature. It reduces harsh chemicals and energy-intensive processes, reducing carbon emissions and waste generation. Biocatalysts are derived from renewable sources and operate under mild conditions, aligning with the growing demand for sustainable manufacturing practices.

The hydrolases type segment is expected to dominate the global liquid packaging market, which accounts for 45 % of the total market shares and is estimated to reach 47% by 2030.

Market Dynamics

Demand For Materials With The Less Environmental Impacts

The demand for sustainable materials is not only driven by environmental concerns but also by consumer preferences. Consumers are increasingly aware of the environmental impact of products and are willing to pay more for sustainable and eco-friendly products. Biocatalysis allows manufacturers to meet consumer demand while reducing their environmental impact.

The development of biocatalytic processes requires significant investment in research and development. However, as the demand for sustainable materials grows, biocatalysis costs are expected to decrease, making it a more viable option for manufacturers. In addition, biotechnology and genetic engineering advances are expected to improve biocatalytic processes' efficiency and versatility.

Drawbacks Related To Biocatalysis Hamper The Market

Some drawbacks of biocatalysis include the inability of biocatalysts to be designed, the stability limits of these catalysts and the scarcity of well-characterized, ready-to-use catalysts. The insufficient amounts of water required for the biocatalyst process is another drawback that is frequently brought up.

The unfolded polypeptide chain is highly mobile and capable of populating various conformations. It does not interact with itself often, though (low enthalpy). It will bind many water molecules in the solution, limiting their motion.

Thus, several energetically advantageous and disadvantageous) processes are involved in the conversion to the folded state. With free energies of folding in the range of 20-60 kJ mol1 (i.e., equivalent to a few hydrogen bonds), these typically balance out to be marginally good overall biocatalysis process.

COVID-19 Impact Analysis

The growing demand from the food, beverage and cosmetics industries positively impacts COVID-19 for the global biocatalysis market. Food and beverage operations are impacted by the COVID-19 pandemic because lockdowns and stay-at-home instructions have been issued in most countries.

The market has seen panic buying for food and daily necessities in many locations. Due to the widespread use of biocatalysis in these sectors, the operation directly restrains the expansion of the biocatalysis market during the pandemic.

Russia-Ukraine War Impact Analysis

The geopolitical situation can influence investment decisions and research priorities in the biocatalysis sector. Companies and research institutions may reassess their strategies and redirect resources away from regions affected by the conflict, potentially impacting innovation and market growth in those areas.

Artificial Intelligence Impact Analysis

AI technologies like machine learning and predictive modeling can optimize biocatalysis processes by analyzing experimental data and identifying optimal reaction conditions. AI algorithms can recognize patterns, identify bottlenecks and suggest process modifications, improving efficiency, productivity and cost-effectiveness.

Segment Analysis

The Global Biocatalysis Market is segmented based on type, source, application and region.

Oxidoreductase-Based Catalysis: Applications And Potential For Boosting Sustainability

The OXIPRO project, supported by the EU, will investigate oxidoreductases, a potential but underutilized method for boosting sustainability. Oxidoreductases are adaptable and have a wide range of uses, such as recovering value from trash, substituting healthy oxidizers and improving the look, feel and durability of consumer goods.

For a smooth transition to more environmentally friendly detergents, textiles, nutraceuticals and cosmetics, OXIPRO will jointly create an oxidoreductase foundry. To shorten the time OXIPRO solutions take to reach the market, the project will create advanced generic technology platforms based on enzyme intelligence and enzyme technologies. Hydrolases is the fastest growing segment with a CAGR of 5.8% globally.

Geographical Analysis

Biocatalysis In The Food Industry And Market Boom In The Biopharma Sectors Of India And China

The biopharma sector in India and China is witnessing a major market boom due to the availability of skilled human capital, government support and epidemiological factors. With a population of 1.3 billion people, half under 25, India has a big pool of young and skilled workers.

Moreover, India boasts a significant pool of scientific talent, including scientists and engineers. The case scenario is identical for China and Market Boom in the Biopharma Sectors of India and China. India holds 36% of the regional share and is expected to generate US$ 41.21 million of growth prospects during the forecast period.

Competitive Landscape

The major global players include: Biocatalysts Limited, Novozymes A/S, Codexis, Inc., Koninklijke DSM N.V., Chr. Hansen Holding A/S, Amano Enzyme, Inc., BASF SE, Fermenta Biotech Ltd, Piramal Enterprises Ltd. and EnginZyme AB.

Why Purchase the Report?

  • To visualize the global biocatalysis market segmentation based on type, source, application and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of biocatalysis market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The Global Biocatalysis Market Report Would Provide Approximately 61 Tables, 63 Figures And 172 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet By Source
  • 3.3. Snippet By Application
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Demand for materials with the less environmental impacts
    • 4.1.2. Restraints
      • 4.1.2.1. Drawbacks related to biocatalysis hamper the market
    • 4.1.3. Opportunity
      • 4.1.3.1. The advanced technology in biocatalysis creates a lucrative opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. During COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Oxidoreductases*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Hydrolases
  • 7.4. Transferases
  • 7.5. Others

8. By Source

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 8.1.2. Market Attractiveness Index, By Source
  • 8.2. Plants*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Animals
  • 8.4. Microorganisms
  • 8.5. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Food & Beverages*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Cleaning Agents
  • 9.4. Fragrance & Flavors
  • 9.5. Agriculture and Feed
  • 9.6. Biopharmaceuticals
  • 9.7. Paper & Pulp
  • 9.8. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1.1. The U.S.
      • 10.2.6.1.2. Canada
      • 10.2.6.1.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1.1. Germany
      • 10.3.6.1.2. The UK
      • 10.3.6.1.3. France
      • 10.3.6.1.4. Italy
      • 10.3.6.1.5. Russia
      • 10.3.6.1.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1.1. Brazil
      • 10.4.6.1.2. Argentina
      • 10.4.6.1.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1.1. China
      • 10.5.6.1.2. India
      • 10.5.6.1.3. Japan
      • 10.5.6.1.4. Australia
      • 10.5.6.1.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Biocatalysts Limited*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Novozymes A/S
  • 12.3. Codexis, Inc.
  • 12.4. Koninklijke DSM N.V.
  • 12.5. Chr. Hansen Holding A/S
  • 12.6. Amano Enzyme, Inc.,
  • 12.7. BASF SE
  • 12.8. Fermenta Biotech Ltd
  • 12.9. Piramal Enterprises Ltd.
  • 12.10. EnginZyme AB.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us